| 摘要 |
The present invention relates to an anhydrous dipotassium alendronic acid salt and the dipotassium alendronic acid salt hydrates e.g. dipotassium alendronic acid salt pentahydrate. The present invention also relates to pharmaceutical preparations comprising as active ingredient the anhydrous dipotassium alendronic acid salt one of the dipotassium alendronic acid salt hydrates. The pharmaceutical preparation may be a tablet, a pellet, a film, sugar or enterocoated tablet or pellet, a capsule, a suspension, a solution, an emulsion, etc. |
